Women Can Expect Hot Flush Relief Following EMA Greenlight

Lynkuet, a dual neurokinin receptor antagonist, showed meaningful reductions in hot flush frequency and severity in postmenopausal women and breast cancer patients in clinical trials.

from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/women-can-expect-hot-flush-relief-following-ema-greenlight-2025a1000p78
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started